JPWO2020157210A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020157210A5 JPWO2020157210A5 JP2021544406A JP2021544406A JPWO2020157210A5 JP WO2020157210 A5 JPWO2020157210 A5 JP WO2020157210A5 JP 2021544406 A JP2021544406 A JP 2021544406A JP 2021544406 A JP2021544406 A JP 2021544406A JP WO2020157210 A5 JPWO2020157210 A5 JP WO2020157210A5
- Authority
- JP
- Japan
- Prior art keywords
- binding molecule
- sequence
- amino acid
- specific binding
- binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1901305.1 | 2019-01-30 | ||
| GBGB1901305.1A GB201901305D0 (en) | 2019-01-30 | 2019-01-30 | Specific binding molecules |
| PCT/EP2020/052315 WO2020157210A1 (en) | 2019-01-30 | 2020-01-30 | Cd3-specific binding molecules |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022523507A JP2022523507A (ja) | 2022-04-25 |
| JPWO2020157210A5 true JPWO2020157210A5 (https=) | 2023-03-10 |
| JP2022523507A5 JP2022523507A5 (https=) | 2023-03-10 |
| JP7530904B2 JP7530904B2 (ja) | 2024-08-08 |
Family
ID=65997940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544406A Active JP7530904B2 (ja) | 2019-01-30 | 2020-01-30 | 特異的結合性分子 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12590152B2 (https=) |
| EP (1) | EP3917959A1 (https=) |
| JP (1) | JP7530904B2 (https=) |
| KR (1) | KR20210121141A (https=) |
| CN (1) | CN113728005B (https=) |
| AU (1) | AU2020215776A1 (https=) |
| BR (1) | BR112021014963A2 (https=) |
| CA (1) | CA3127144A1 (https=) |
| GB (1) | GB201901305D0 (https=) |
| IL (1) | IL284926B2 (https=) |
| MX (1) | MX2021009275A (https=) |
| WO (1) | WO2020157210A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12162940B2 (en) | 2021-05-05 | 2024-12-10 | Immatics Biotechnologies Gmbh | BMA031 antigen binding polypeptides |
| CN115724988B (zh) * | 2021-08-26 | 2023-11-17 | 瑅安生物医药（杭州）有限公司 | 一种接近天然分子的多肽融合分子 |
| KR20240149435A (ko) | 2022-02-20 | 2024-10-14 | 이뮤노코어 리미티드 | Hiv 특이적 결합 분자 |
| MX2025001960A (es) | 2022-08-18 | 2025-05-02 | Immunocore Ltd | Moléculas de unión multidominio |
| US12134647B2 (en) | 2023-01-06 | 2024-11-05 | Immunocore Limited | Binding molecules |
| US12195534B2 (en) | 2023-01-06 | 2025-01-14 | Immunocore Limited | Binding molecules |
| TW202519257A (zh) * | 2023-08-01 | 2025-05-16 | 英商英美偌科有限公司 | 治療皮膚黑色素瘤之方法 |
| WO2025050404A1 (zh) * | 2023-09-08 | 2025-03-13 | 成都维瑾柏鳌生物医药科技有限公司 | 一种药物组合物及其应用 |
| GB202320012D0 (en) | 2023-12-22 | 2024-02-07 | Immunocore Ltd | Bispecific molecules |
| GB2641580A (en) | 2024-06-07 | 2025-12-10 | T Therapeutics Ltd | Tumour-transforming multispecific proteins |
| WO2026078231A1 (en) | 2024-10-11 | 2026-04-16 | T-Therapeutics Limited | Soluble non-aggregating immune ligand |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US36676A (en) | 1862-10-14 | Improvement in grain-cleaners | ||
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| AU7757581A (en) | 1980-11-19 | 1982-05-27 | United Energy Technologies Inc. | Enhanced surface tubing |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| JPS5855530Y2 (ja) | 1981-06-15 | 1983-12-20 | 松下電工株式会社 | 照明器具を有する天井 |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| DE3374837D1 (en) | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
| DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4630115A (en) | 1983-05-09 | 1986-12-16 | The General Electric Company, P.L.C. | Cathode ray tube display device |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| EP0143949B1 (en) | 1983-11-01 | 1988-10-12 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Pharmaceutical composition containing urokinase |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| DE69232137T2 (de) | 1991-11-25 | 2002-05-29 | Enzon Inc | Multivalente antigen-bindende proteine |
| ATE199392T1 (de) | 1992-12-04 | 2001-03-15 | Medical Res Council | Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung |
| AU6685698A (en) | 1997-03-07 | 1998-09-22 | Sunol Molecular Corporation | Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor |
| WO1999018129A1 (en) | 1997-10-02 | 1999-04-15 | Sunol Molecular Corporation | Soluble single-chain t-cell receptor proteins |
| WO2001062908A2 (en) | 2000-02-22 | 2001-08-30 | Ahuva Nissim | Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| CN101289511A (zh) | 2000-04-11 | 2008-10-22 | 杰南技术公司 | 多价抗体及其应用 |
| AU2002321581C1 (en) | 2001-08-31 | 2008-09-18 | Adaptimmune Limited | Soluble T cell receptor |
| AU2003271904B2 (en) | 2002-10-09 | 2009-03-05 | Adaptimmune Limited | Single chain recombinant T cell receptors |
| US8361794B2 (en) | 2004-06-29 | 2013-01-29 | Immunocore Limited | Cells expressing a modified T cell receptor |
| US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| GB0908613D0 (en) * | 2009-05-20 | 2009-06-24 | Immunocore Ltd | T Cell Reseptors |
| GB0911566D0 (en) | 2009-07-03 | 2009-08-12 | Immunocore Ltd | T cell receptors |
| WO2014012085A2 (en) | 2012-07-13 | 2014-01-16 | Zymeworks Inc. | Bispecific asymmetric heterodimers comprising anti-cd3 constructs |
| UA129760C2 (uk) * | 2013-12-17 | 2025-07-30 | Дженентек, Інк. | Анти-cd3 антитіло та спосіб його застосування |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
| GB201522592D0 (en) | 2015-12-22 | 2016-02-03 | Immunocore Ltd | T cell receptors |
| PL3440105T3 (pl) | 2016-04-08 | 2022-08-29 | Immunocore Limited | Receptory komórek t |
| GB201709866D0 (en) * | 2017-06-20 | 2017-08-02 | Immunocore Ltd | T cell receptors |
| GB201915282D0 (en) * | 2019-10-22 | 2019-12-04 | Immunocore Ltd | Specific binding molecules |
| GB202006629D0 (en) * | 2020-05-05 | 2020-06-17 | Immunocore Ltd | Specific binding molecules |
| US12103971B2 (en) * | 2022-02-20 | 2024-10-01 | Immunocore Limited | HIV specific binding molecules |
| CA3265218A1 (en) * | 2022-08-18 | 2024-02-22 | Immunocore Ltd | MAGE A4 SPECIFIC T LYMPHOCYTE RECEPTOR FUSION PROTEINS |
| US12195534B2 (en) * | 2023-01-06 | 2025-01-14 | Immunocore Limited | Binding molecules |
| US12134647B2 (en) * | 2023-01-06 | 2024-11-05 | Immunocore Limited | Binding molecules |
-
2019
- 2019-01-30 GB GBGB1901305.1A patent/GB201901305D0/en not_active Ceased
-
2020
- 2020-01-30 CA CA3127144A patent/CA3127144A1/en active Pending
- 2020-01-30 AU AU2020215776A patent/AU2020215776A1/en active Pending
- 2020-01-30 WO PCT/EP2020/052315 patent/WO2020157210A1/en not_active Ceased
- 2020-01-30 BR BR112021014963-5A patent/BR112021014963A2/pt unknown
- 2020-01-30 MX MX2021009275A patent/MX2021009275A/es unknown
- 2020-01-30 CN CN202080012045.4A patent/CN113728005B/zh active Active
- 2020-01-30 KR KR1020217027112A patent/KR20210121141A/ko active Pending
- 2020-01-30 US US17/427,592 patent/US12590152B2/en active Active
- 2020-01-30 EP EP20703192.3A patent/EP3917959A1/en active Pending
- 2020-01-30 IL IL284926A patent/IL284926B2/en unknown
- 2020-01-30 JP JP2021544406A patent/JP7530904B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6023172B2 (ja) | 交差結合領域の配向性を有する二重可変領域抗体様結合タンパク質 | |
| JP2021528973A5 (https=) | ||
| JP2019216719A (ja) | Ｃｄ４７に対するヒト化及びキメラモノクローナル抗体 | |
| US20160009824A1 (en) | Tetravalent bispecific antibodies | |
| JP2017529067A (ja) | Ｃｄ３結合ドメイン | |
| HRP20191083T1 (hr) | Molekule antitijela za tim-3 i njihove upotrebe | |
| JP2013500703A5 (https=) | ||
| US11365240B2 (en) | Anti-HSA antibodies | |
| JP7679399B2 (ja) | 抗ｆｌｔ３抗体及び組成物 | |
| JP2024177499A (ja) | 血液脳関門輸送の促進のためのヒト化され安定化されたｆｃ５バリアント | |
| JPWO2020157210A5 (https=) | ||
| JPWO2020010079A5 (https=) | ||
| CN114786720A (zh) | TriAx抗体的组合物及其制备和使用方法 | |
| KR20240031229A (ko) | 알파-시누클레인병증 치료용 항체 | |
| CN118459583B (zh) | 抗N3pGlu淀粉样蛋白β抗体及其用途 | |
| JPWO2022104236A5 (https=) | ||
| CA3143957A1 (en) | Anti-pd-l1 antibodies | |
| WO2024225446A1 (ja) | 新規なＮａｖ１．７モノクローナル抗体を含む医薬組成物 | |
| US20250257113A1 (en) | Multivalent sirp-alpha fusion polypeptides | |
| Benedetti et al. | Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains | |
| JP2025526279A (ja) | 抗ＴＮＦα抗体および組成物 | |
| WO2023143273A1 (zh) | 新型长效化和高活性且更安全的抗体构建体 | |
| RU2021121683A (ru) | Cd-3-специфические связывающие молекулы | |
| US20250154242A1 (en) | Anti-tnf-alpha antibodies and compositions | |
| TWI918721B (zh) | Egfr結合複合物及其製備和使用方法 |